[{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Chairperson","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>Shivaani Kummar<\/i><\/u><\/presenter>. OHSU Knight Cancer Institute, Portland, OR","CSlideId":"","ControlKey":"686c1e48-f9dd-45cf-b64e-85ffdd7b2a64","ControlNumber":"75","DisclosureBlock":"&nbsp;<b>&nbsp;S. Kummar:<\/b>  ; Arxeon. ; Bayer HealthCare Pharmaceuticals Inc.. ; Boehringer Ingelheim. ; Gilead Sciences Inc. ; Harbour Biomed. ; Mirati. ; MundiBiopharma. ; Oxford Biotherapeutics. ; Pathomiq. ; Springworks Therapeutics. ; cadila.","End":"4\/18\/2023 12:31:00 PM","HasWebcast":null,"Highlights":[],"Id":"73","IsPresentation":"False","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"1","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Shivaani Kummar, MD","PresenterKey":"e08b9b64-979f-4802-a925-ea9b07162600","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Chairperson","SearchResultFooter":"","SearchResultHeader":"Apr 18 2023 12:30PM","SessionId":"40","SessionOnDemand":"False","SessionTitle":"Future of Phase I Clinical Trials","ShowChatLink":"false","Start":"4\/18\/2023 12:30:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Chairperson","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Invited Speaker","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>Shivaani Kummar<\/i><\/u><\/presenter>. OHSU Knight Cancer Institute, Portland, OR","CSlideId":"","ControlKey":"155d80ca-5a31-4014-a19f-4fe58e2e0817","ControlNumber":"10337","DisclosureBlock":"<b>&nbsp;S. Kummar, <\/b> <br><b>Arxeon<\/b> S, S. <br><b>Bayer HealthCare Pharmaceuticals Inc.<\/b> I, I. <br><b>Boehringer Ingelheim<\/b> I, I. <br><b>Gilead Sciences Inc<\/b> I, I. <br><b>Harbour Biomed<\/b> I, I. <br><b>Mirati<\/b> I, I. <br><b>MundiBiopharma<\/b> I, I. <br><b>Oxford Biotherapeutics<\/b> I, I. <br><b>Pathomiq<\/b> S, S. <br><b>Seagen Inc.<\/b> I, I. <br><b>Springworks Therapeutics<\/b> I, I. <br><b>cadila<\/b> I, I. <br><b>genome & company<\/b> I, I.","End":"4\/18\/2023 12:35:00 PM","HasWebcast":null,"Highlights":[],"Id":"9113","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"2","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Shivaani Kummar, MD","PresenterKey":"e08b9b64-979f-4802-a925-ea9b07162600","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Chair Introduction","SearchResultFooter":"","SearchResultHeader":"Apr 18 2023 12:30PM","SessionId":"40","SessionOnDemand":"False","SessionTitle":"Future of Phase I Clinical Trials","ShowChatLink":"false","Start":"4\/18\/2023 12:30:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Chair Introduction","Topics":null,"cSlideId":""},{"Abstract":"The stunning pace of basic-science breakthroughs in multiple areas of oncology like genomics, immunology, epigenetics, microbiomes, and CRISPR\/CAS9 technologies are accelerating. Phase 1 clinical trials are crucial for translating each one of these science advances. Transformation of Phase 1 trials from just dose-finding\/toxicity studies to seamless studies leading to accelerated US FDA approval in the era of precision oncology has been enabled by tissue\/blood-based &#8216;omic technologies and evolution in drug design. Traditional Phase 1 trial design paradigms must evolve to match these advances to accelerate drug development.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Invited Speaker","AdditionalFields":[{"Key":"Topics","Value":"++CT01-01 Phase I adult clinical trials,,"},{"Key":"Keywords","Value":"Therapeutic target,Therapeutics,Precision medicine,Kinase inhibitors,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>Vivek Subbiah<\/i><\/u><\/presenter>. UT MD Anderson Cancer Center, Houston, TX","CSlideId":"","ControlKey":"60f58e47-0cf1-45d9-b478-8d3de8fadeb9","ControlNumber":"8315","DisclosureBlock":"<b>&nbsp;V. Subbiah, <\/b> <br><b>AbbVie, Inc.<\/b> G. <br><b>Agensys<\/b> G. <br><b>American Society of Clinical Oncology<\/b> T. <br><b>Amgen Inc.<\/b> G. <br><b>Bayer HealthCare Pharmaceuticals Inc.<\/b> G. <br><b>Berghealth<\/b> G. <br><b>Blueprint medicines<\/b> G. <br><b>Boston Biomedical<\/b> G. <br><b>D3<\/b> G. <br><b>Dagonflytherapeutics<\/b> G. <br><b>Eli Lilly and Company<\/b> G. <br><b>European society of medical oncology<\/b> T. <br><b>Exelixis Inc.<\/b> G. <br><b>FUJIFILM Medical Systems USA, Inc.<\/b> G. <br><b>Genentech USA, Inc.<\/b> G. <br><b>GlaxoSmithKline, LLC.<\/b> G. <br><b>Helsinn Healthcare SA<\/b> T. <br><b>Idera Pharma<\/b> G. <br><b>Incyte Corporation<\/b> I, G, T. <br><b>Inhibrx<\/b> G. <br><b>LOXO Oncology<\/b> G. <br><b>MedImmune, LLC<\/b> G. <br><b>Medscape<\/b> I. <br><b>National Cancer Institute<\/b> G. <br><b>National Comprehensive Cancer Network<\/b> G. <br><b>Northwest Biotherapeutics<\/b> G. <br><b>Novartis Pharma<\/b> G. <br><b>Pfizer<\/b> G. <br><b>Pharmamar<\/b> G. <br><b>Takeda Oncology<\/b> G. <br><b>The University of Texas MD Anderson Cancer Center<\/b> E.","End":"4\/18\/2023 12:55:00 PM","HasWebcast":null,"Highlights":[],"Id":"838","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"3","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Vivek Subbiah, MD","PresenterKey":"af8da20e-d2a9-4ed0-8526-7504ffd27fce","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Revolution in the precision medicine paradigm in phase 1 trials: The future is now","SearchResultFooter":"","SearchResultHeader":"Apr 18 2023 12:30PM","SessionId":"40","SessionOnDemand":"False","SessionTitle":"Future of Phase I Clinical Trials","ShowChatLink":"false","Start":"4\/18\/2023 12:35:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Revolution in the precision medicine paradigm in phase 1 trials: The future is now","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Other","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":". ","CSlideId":"","ControlKey":"9b118fc2-39ed-4f66-b125-87eede4da6eb","ControlNumber":"6281","DisclosureBlock":"","End":"4\/18\/2023 1:00:00 PM","HasWebcast":null,"Highlights":[],"Id":"723","IsPresentation":"False","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"4","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":null,"PresenterKey":null,"PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Discussion","SearchResultFooter":"","SearchResultHeader":"Apr 18 2023 12:30PM","SessionId":"40","SessionOnDemand":"False","SessionTitle":"Future of Phase I Clinical Trials","ShowChatLink":"false","Start":"4\/18\/2023 12:55:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Discussion","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Invited Speaker","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>Patricia M. LoRusso<\/i><\/u><\/presenter>. Yale School of Medicine, Hamden, CT","CSlideId":"","ControlKey":"58c94bcd-6b45-404a-8f23-300062769bc9","ControlNumber":"6225","DisclosureBlock":"","End":"4\/18\/2023 1:20:00 PM","HasWebcast":null,"Highlights":[],"Id":"720","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"5","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Patricia LoRusso, DO;PhD (hc)","PresenterKey":"e04ae404-5217-4b96-8a03-7124c6f46469","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Antibody drug conjugates: Selection, drug resistance, and combinations","SearchResultFooter":"","SearchResultHeader":"Apr 18 2023 12:30PM","SessionId":"40","SessionOnDemand":"False","SessionTitle":"Future of Phase I Clinical Trials","ShowChatLink":"false","Start":"4\/18\/2023 1:00:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Antibody drug conjugates: Selection, drug resistance, and combinations","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Other","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":". ","CSlideId":"","ControlKey":"082e52dd-c47d-4c72-ae85-6d5d447bdad3","ControlNumber":"6282","DisclosureBlock":"","End":"4\/18\/2023 1:25:00 PM","HasWebcast":null,"Highlights":[],"Id":"724","IsPresentation":"False","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"6","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":null,"PresenterKey":null,"PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Discussion","SearchResultFooter":"","SearchResultHeader":"Apr 18 2023 12:30PM","SessionId":"40","SessionOnDemand":"False","SessionTitle":"Future of Phase I Clinical Trials","ShowChatLink":"false","Start":"4\/18\/2023 1:20:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Discussion","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Invited Speaker","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>Shivaani Kummar<\/i><\/u><\/presenter>. OHSU Knight Cancer Institute, Portland, OR","CSlideId":"","ControlKey":"222fe88b-4688-4a6c-aeb8-ed8b625d5b16","ControlNumber":"1314","DisclosureBlock":"<b>&nbsp;S. Kummar, <\/b> <br><b>Arxeon<\/b> S. <br><b>Bayer HealthCare Pharmaceuticals Inc.<\/b> I. <br><b>Boehringer Ingelheim<\/b> I. <br><b>Gilead Sciences Inc<\/b> I. <br><b>Harbour Biomed<\/b> I. <br><b>Mirati<\/b> I. <br><b>MundiBiopharma<\/b> I. <br><b>Oxford Biotherapeutics<\/b> I. <br><b>Pathomiq<\/b> S. <br><b>Springworks Therapeutics<\/b> I. <br><b>cadila<\/b> I.","End":"4\/18\/2023 1:45:00 PM","HasWebcast":null,"Highlights":[],"Id":"462","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"7","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Shivaani Kummar, MD","PresenterKey":"e08b9b64-979f-4802-a925-ea9b07162600","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Immunotherapies: Where do we go next?","SearchResultFooter":"","SearchResultHeader":"Apr 18 2023 12:30PM","SessionId":"40","SessionOnDemand":"False","SessionTitle":"Future of Phase I Clinical Trials","ShowChatLink":"false","Start":"4\/18\/2023 1:25:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Immunotherapies: Where do we go next?","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Other","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":". ","CSlideId":"","ControlKey":"5910a72d-cdc4-4b3d-a268-77b5c4db49ef","ControlNumber":"6288","DisclosureBlock":"","End":"4\/18\/2023 1:50:00 PM","HasWebcast":null,"Highlights":[],"Id":"725","IsPresentation":"False","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"8","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":null,"PresenterKey":null,"PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Discussion","SearchResultFooter":"","SearchResultHeader":"Apr 18 2023 12:30PM","SessionId":"40","SessionOnDemand":"False","SessionTitle":"Future of Phase I Clinical Trials","ShowChatLink":"false","Start":"4\/18\/2023 1:45:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Discussion","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Other","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":". ","CSlideId":"","ControlKey":"d6b167a6-c856-430f-a448-0d6c0bd3b41f","ControlNumber":"6289","DisclosureBlock":"","End":"4\/18\/2023 2:00:00 PM","HasWebcast":null,"Highlights":[],"Id":"726","IsPresentation":"False","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"9","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":null,"PresenterKey":null,"PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"General Discussion","SearchResultFooter":"","SearchResultHeader":"Apr 18 2023 12:30PM","SessionId":"40","SessionOnDemand":"False","SessionTitle":"Future of Phase I Clinical Trials","ShowChatLink":"false","Start":"4\/18\/2023 1:50:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"General Discussion","Topics":null,"cSlideId":""}]